These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10637819)

  • 1. [Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect].
    Puls I; Beck M; Giess R; Magnus T; Ochs G; Toyka KV
    Nervenarzt; 1999 Dec; 70(12):1112-5. PubMed ID: 10637819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot trial with clenbuterol in amyotrophic lateral sclerosis.
    Sorarù G; Pegoraro E; Spinella P; Turra S; D'Ascenzo C; Baggio L; Mantovan MC; Vergani L; Angelini C
    Amyotroph Lateral Scler; 2006 Dec; 7(4):246-8. PubMed ID: 17127564
    [No Abstract]   [Full Text] [Related]  

  • 3. Clenbuterol retards loss of motor function in motor neuron degeneration mice.
    Zeman RJ; Peng H; Etlinger JD
    Exp Neurol; 2004 Jun; 187(2):460-7. PubMed ID: 15144872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clenbuterol impairs muscle quality and is potentially dangerous.
    Habedank D; Steeg M; Anker SD
    J Heart Lung Transplant; 2008 Aug; 27(8):934-5. PubMed ID: 18656813
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis.
    Teng YD; Choi H; Huang W; Onario RC; Frontera WR; Snyder EY; Sabharwal S
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):155-8. PubMed ID: 16388902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure.
    Kamalakkannan G; Petrilli CM; George I; LaManca J; McLaughlin BT; Shane E; Mancini DM; Maybaum S
    J Heart Lung Transplant; 2008 Apr; 27(4):457-61. PubMed ID: 18374884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clenbuterol and the horse revisited.
    Kearns CF; McKeever KH
    Vet J; 2009 Dec; 182(3):384-91. PubMed ID: 18926742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: beta-2 adrenergic agonists.
    Brooks BR; Juhasz-Poscine K; Waclawik A; Sanjak M; Belden D; Roelke K; Parnell J; Weasler C
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1 Suppl 4():45-53; discussion 53-4. PubMed ID: 11466959
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clenbuterol: 'redistribution agent'].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1988 Sep; 132(39):1782-5. PubMed ID: 2903453
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies].
    Oya Y; Ogawa M; Kawai M
    Rinsho Shinkeigaku; 2001 Oct; 41(10):698-700. PubMed ID: 11993192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity From Unintentional Pediatric Ingestion of a Performance-Enhancing Drug: A Case Report With Review of Clenbuterol Toxicity and Treatment.
    Bonney CF; Hatten B; Wang GS
    J Emerg Med; 2019 Oct; 57(4):e105-e108. PubMed ID: 31493966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of motor urge incontinence with the beta 2-sympathomimetic drug clenbuterol (author's transl)].
    Grüneberger A; Geier G
    Urologe A; 1981 May; 20(3):153-4. PubMed ID: 6115496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
    Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
    Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clenbuterol: a substitute for anabolic steroids?
    Prather ID; Brown DE; North P; Wilson JR
    Med Sci Sports Exerc; 1995 Aug; 27(8):1118-21. PubMed ID: 7476054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot trial of clenbuterol in spinal and bulbar muscular atrophy.
    Querin G; D'Ascenzo C; Peterle E; Ermani M; Bello L; Melacini P; Morandi L; Mazzini L; Silani V; Raimondi M; Mandrioli J; Romito S; Angelini C; Pegoraro E; Sorarù G
    Neurology; 2013 Jun; 80(23):2095-8. PubMed ID: 23645595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma].
    Yamamoto H; Nagata M; Tabe K; Suzuki S; Maruo H; Sakamoto Y; Yamamoto K; Dohi Y
    Arerugi; 1990 Jan; 39(1):21-7. PubMed ID: 1972011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
    Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of beta2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia.
    Zhu Y; Culmsee C; Semkova I; Krieglstein J
    J Cereb Blood Flow Metab; 1998 Sep; 18(9):1032-9. PubMed ID: 9740107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of clenbuterol on intramuscular collagen metabolism in denervated muscle].
    Jiang G; Gu Y; Zhang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1998 Jan; 12(1):48-51. PubMed ID: 10374624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridge to recovery with the use of left ventricular assist device and clenbuterol.
    Hon JK; Yacoub MH
    Ann Thorac Surg; 2003 Jun; 75(6 Suppl):S36-41. PubMed ID: 12820733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.